Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ICU logo ICU
Upturn stock ratingUpturn stock rating
ICU logo

LMF Acquisition Opportunities Inc (ICU)

Upturn stock ratingUpturn stock rating
$0.86
Last Close (24-hour delay)
Profit since last BUY-4.44%
upturn advisory
Consider higher Upturn Star rating
BUY since 16 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/17/2025: ICU (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $2

1 Year Target Price $2

Analysts Price Target For last 52 week
$2 Target price
52w Low $0.31
Current$0.86
52w High $5.12

Analysis of Past Performance

Type Stock
Historic Profit -25.82%
Avg. Invested days 20
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/17/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 24.70M USD
Price to earnings Ratio -
1Y Target Price 2
Price to earnings Ratio -
1Y Target Price 2
Volume (30-day avg) 1
Beta -0.97
52 Weeks Range 0.31 - 5.12
Updated Date 09/17/2025
52 Weeks Range 0.31 - 5.12
Updated Date 09/17/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.85

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -519.53%

Management Effectiveness

Return on Assets (TTM) -156.15%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 19771417
Price to Sales(TTM) 32.25
Enterprise Value 19771417
Price to Sales(TTM) 32.25
Enterprise Value to Revenue 25.81
Enterprise Value to EBITDA -8.13
Shares Outstanding 27914600
Shares Floating 27645778
Shares Outstanding 27914600
Shares Floating 27645778
Percent Insiders 1.01
Percent Institutions 6.98

ai summary icon Upturn AI SWOT

LMF Acquisition Opportunities Inc

stock logo

Company Overview

overview logo History and Background

LMF Acquisition Opportunities Inc. (LMAO) is a blank check company, also known as a special purpose acquisition company (SPAC). SPACs are formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. LMAO was likely founded recently, with the IPO date being the starting point of its operational history.

business area logo Core Business Areas

  • SPAC Formation: Raising capital through an IPO to fund a future acquisition.
  • Target Identification and Acquisition: Identifying and acquiring a private company, thus taking it public through a reverse merger.

leadership logo Leadership and Structure

Typically, SPACs are led by a management team with experience in private equity, investment banking, or the target industry. The structure usually involves a board of directors and an executive team responsible for deal sourcing and negotiation.

Top Products and Market Share

overview logo Key Offerings

  • Initial Public Offering (IPO): Offering shares to the public to raise capital. SPAC market share is fluid, depending on IPO success and acquisition targets. Competitors include other SPACs such as CF Acquisition Corp. VIII (CFFE) and D and Z Media Acquisition Corp. (DNZ).

Market Dynamics

industry overview logo Industry Overview

The SPAC market has seen fluctuations in popularity. SPACs offer a faster route to public markets compared to traditional IPOs but are subject to regulatory scrutiny and investor sentiment.

Positioning

LMF Acquisition Opportunities Inc. is a participant in the SPAC market, seeking to acquire a target company. Its success depends on its management team's ability to find a suitable acquisition target and complete the deal.

Total Addressable Market (TAM)

The TAM for SPACs is difficult to quantify precisely, but represents the total value of companies that could potentially become public via a SPAC merger. LMAO's success in capturing a portion of this TAM depends on identifying and acquiring a target company with growth potential.

Upturn SWOT Analysis

Strengths

  • Access to public capital
  • Experienced management team (potentially)
  • Flexibility in target company selection

Weaknesses

  • Dependence on finding a suitable acquisition target
  • Time constraints for completing a deal
  • Potential for dilution through warrant exercises

Opportunities

  • Acquiring a high-growth company
  • Capitalizing on favorable market conditions
  • Creating shareholder value through successful integration

Threats

  • Increased regulatory scrutiny of SPACs
  • Competition from other SPACs
  • Market volatility impacting deal valuations

Competitors and Market Share

competitor logo Key Competitors

  • CF Acquisition Corp. VIII (CFFE)
  • D and Z Media Acquisition Corp. (DNZ)

Competitive Landscape

The SPAC landscape is highly competitive, with numerous SPACs searching for targets. Success depends on deal sourcing, negotiation skills, and the attractiveness of the acquired company.

Growth Trajectory and Initiatives

Historical Growth: N/A until acquisition

Future Projections: Future growth depends entirely on the acquired company's performance.

Recent Initiatives: Searching for an acquisition target is the primary ongoing initiative.

Summary

LMF Acquisition Opportunities Inc. is a SPAC actively seeking an acquisition target. Its success hinges on identifying a suitable company and completing a successful merger. The SPAC market is competitive, and LMAO faces risks related to regulatory scrutiny and market volatility. The company's future performance depends entirely on the quality of the acquired company.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings
  • Financial news sources
  • Market analysis reports

Disclaimers:

This analysis is based on publicly available information and is not financial advice. SPACs are inherently speculative investments.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About LMF Acquisition Opportunities Inc

Exchange NASDAQ
Headquaters Denver, CO, United States
IPO Launch date 2022-10-28
CEO, Interim Chief Financial Officer, Principal Financial Officer, Treasurer & Executive Director Mr. Eric Schlorff
Sector Healthcare
Industry Biotechnology
Full time employees 19
Full time employees 19

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.